Tacrolimus as Antifungal Agent
Tacrolimus (FK506) is an immunosuppressant drug widely used to avoid organ rejection in transplant patients. It has a profound influence on the cellular stress response by interfering with the calmodulin-calcineurin signaling pathway. In this context FK506 also became a valuable antifungal drug in m...
| Published in: | Acta Chimica Slovenica |
|---|---|
| Main Authors: | Lyudmyla Antypenko, Fatuma Meyer, Zhanar Sadykova, Leif-Alexander Garbe, Karl G. Steffens |
| Format: | Article |
| Language: | English |
| Published: |
Slovenian Chemical Society
2019-12-01
|
| Subjects: | |
| Online Access: | https://journals.matheo.si/index.php/ACSi/article/view/4723 |
Similar Items
Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1<i>H</i>-1,2,4-triazol-5-yl)phenyl}amines as Antifungals: <i>In Vitro</i> Growth Inhibition and <i>In Silico</i> Molecular Docking Analysis to Fungal Chitin Deacetylase
by: Lyudmyla Antypenko, et al.
Published: (2023-01-01)
by: Lyudmyla Antypenko, et al.
Published: (2023-01-01)
Monomethyl Suberate Screening for Antifungal Activity, Molecular Docking and Drug-Like Properties
by: Lyudmyla Antypenko, et al.
Published: (2018-12-01)
by: Lyudmyla Antypenko, et al.
Published: (2018-12-01)
Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01)
by: Emrah Günay
Published: (2020-09-01)
Tacrolimus—why pharmacokinetics matter in the clinic
by: Lino Henkel, et al.
Published: (2023-08-01)
by: Lino Henkel, et al.
Published: (2023-08-01)
Anemia hemolítica microangiopática induzida por tacrolimus e ciclosporina A Microangiopathic hemolytic anemia induced by tacrolimus and ciclosporine A
by: Rafael S. Vasconcelos, et al.
Published: (2008-12-01)
by: Rafael S. Vasconcelos, et al.
Published: (2008-12-01)
Controversial Interactions of Tacrolimus with Dietary Supplements, Herbs and Food
by: Miłosz Miedziaszczyk, et al.
Published: (2022-10-01)
by: Miłosz Miedziaszczyk, et al.
Published: (2022-10-01)
Formulation and Characterization of Self-Microemulsifying Drug Delivery System of Tacrolimus
by: Duaa J. Al-Tamimi, et al.
Published: (2021-06-01)
by: Duaa J. Al-Tamimi, et al.
Published: (2021-06-01)
Tacrolimus for Ophthalmic Use: An Update
by: Sana Ilias Tinwala, et al.
Published: (2013-01-01)
by: Sana Ilias Tinwala, et al.
Published: (2013-01-01)
Effectiveness and safety of topical tacrolimus in treatment of vitiligo
by: Ghasem Rahmatpour Rokni, et al.
Published: (2017-01-01)
by: Ghasem Rahmatpour Rokni, et al.
Published: (2017-01-01)
Exfoliative Cheilitis in Childhood: A Successful Treatment with Tacrolimus
by: Emel Ulusoy, et al.
Published: (2023-03-01)
by: Emel Ulusoy, et al.
Published: (2023-03-01)
Tacrolimus-induced cholestatic hepatotoxicity after renal transplantation: a case report
by: Fatemeh Pourrezagholi, et al.
Published: (2024-02-01)
by: Fatemeh Pourrezagholi, et al.
Published: (2024-02-01)
An Uncommon Neurological Complication of Tacrolimus: Foot Drop
by: Vijay Chander Bukka, et al.
Published: (2025-01-01)
by: Vijay Chander Bukka, et al.
Published: (2025-01-01)
The use of extended-release tacrolimus twice a day might be beneficial for selected kidney transplant recipients: a case report
by: Louise Füessl, et al.
Published: (2024-06-01)
by: Louise Füessl, et al.
Published: (2024-06-01)
Tacrolimus for the Treatment of Ulcerative Colitis
by: Katsuyoshi Matsuoka, et al.
Published: (2015-07-01)
by: Katsuyoshi Matsuoka, et al.
Published: (2015-07-01)
Metabolomic Profiling of Mice with Tacrolimus-Induced Nephrotoxicity: Carnitine Deficiency in Renal Tissue
by: Sho Nishida, et al.
Published: (2024-02-01)
by: Sho Nishida, et al.
Published: (2024-02-01)
Therapeutic drug monitoring of tacrolimus in kidney transplantation
by: Shyam Bihari Bansal
Published: (2020-01-01)
by: Shyam Bihari Bansal
Published: (2020-01-01)
Cilastatin protects against tacrolimus-induced nephrotoxicity via anti-oxidative and anti-apoptotic properties
by: Kang Luo, et al.
Published: (2019-06-01)
by: Kang Luo, et al.
Published: (2019-06-01)
The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations
by: Pere Fontova, et al.
Published: (2023-05-01)
by: Pere Fontova, et al.
Published: (2023-05-01)
Revisiting the nature and pharmacodynamics of tacrolimus metabolites
by: Rudy Mevizou, et al.
Published: (2024-11-01)
by: Rudy Mevizou, et al.
Published: (2024-11-01)
Anti-Fibrotic Effect of Tacrolimus on Preventing Adhesion after Achilles Tendon Surgery in a Murine Model
by: Seyedeh Elnaz Nazari, et al.
Published: (2025-08-01)
by: Seyedeh Elnaz Nazari, et al.
Published: (2025-08-01)
CONVERSION TO TACROLIMUS IN PATIENTS WITH LATE ACUTE AND CHRONIC REJECTION OF TRANSPLANTED KIDNEY
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)
by: E. S. Stolyarevich, et al.
Published: (2011-06-01)
Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response
by: Moritz Anft, et al.
Published: (2024-09-01)
by: Moritz Anft, et al.
Published: (2024-09-01)
Intrapatient tacrolimus variability is associated with medical nonadherence among pediatric kidney transplant recipients
by: Tara B. Gavcovich, et al.
Published: (2025-03-01)
by: Tara B. Gavcovich, et al.
Published: (2025-03-01)
Tacrolimus in refractory juvenile dermatomyositis: Case report and review of literature
by: Anand Prahalad Rao, et al.
Published: (2020-01-01)
by: Anand Prahalad Rao, et al.
Published: (2020-01-01)
The Use of Tacrolimus in Ophthalmology: A Review on Chronic and Acute Management
by: Abdulrhman Mustafa Almaghrabi, et al.
Published: (2024-07-01)
by: Abdulrhman Mustafa Almaghrabi, et al.
Published: (2024-07-01)
Generic tacrolimus in kidney transplant patients at Jordan University hospital
by: Ayman M Wahbeh, et al.
Published: (2024-01-01)
by: Ayman M Wahbeh, et al.
Published: (2024-01-01)
Clinical efficacy of tacrolimus combined with glucocorticoids for idiopathic membranous nephropathy
by: LING Yi-sheng, et al.
Published: (2016-01-01)
by: LING Yi-sheng, et al.
Published: (2016-01-01)
Study of Tacrolimus Calibrator and Reagent Matrix Effect
by: Haeyong JUNG
Published: (2025-03-01)
by: Haeyong JUNG
Published: (2025-03-01)
Syphilitic interstitial keratitis treated with topical tacrolimus
by: Jacob Martin, et al.
Published: (2021-09-01)
by: Jacob Martin, et al.
Published: (2021-09-01)
Use of topical tacrolimus in ophthalmology: Nonsystematic review
by: Morgana Arima Vedovato, et al.
Published: (2020-01-01)
by: Morgana Arima Vedovato, et al.
Published: (2020-01-01)
Tacrolimus-induced Ascites after Liver Transplant
by: M Hosseini, et al.
Published: (2018-04-01)
by: M Hosseini, et al.
Published: (2018-04-01)
Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
by: Jong Man Kim, et al.
Published: (2021-09-01)
by: Jong Man Kim, et al.
Published: (2021-09-01)
The Mineralocorticoid Receptor on Smooth Muscle Cells Promotes Tacrolimus-Induced Renal Injury in Mice
by: Stefanny M. Figueroa, et al.
Published: (2023-04-01)
by: Stefanny M. Figueroa, et al.
Published: (2023-04-01)
Milk-alkali syndrome and tacrolimus metabolism
by: Gurbir Singh, et al.
Published: (2022-12-01)
by: Gurbir Singh, et al.
Published: (2022-12-01)
Favorable Results of Concomitant Tacrolimus and Sirolimus Therapy in Taiwanese Renal Transplant Recipients at 12 Months
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)
by: Kuo-Hsin Chen, et al.
Published: (2008-07-01)
Effect of concomitant administration of nifedipine and tacrolimus on the development of gingival overgrowth in rats
by: Sheng-Yi Chen, et al.
Published: (2015-03-01)
by: Sheng-Yi Chen, et al.
Published: (2015-03-01)
Individualized treatment based on single-nucleotide polymorphisms with tacrolimus in ulcerative colitis
by: Shinji Okabayashi, et al.
Published: (2019-04-01)
by: Shinji Okabayashi, et al.
Published: (2019-04-01)
Agmatine Abrogates Tacrolimus-Induced Testicular Injury in Rats
by: Naif Alharbi, et al.
Published: (2025-05-01)
by: Naif Alharbi, et al.
Published: (2025-05-01)
Case Report: Low Hematocrit Leading to Tacrolimus Toxicity
by: Alexandre Piletta-Zanin, et al.
Published: (2021-08-01)
by: Alexandre Piletta-Zanin, et al.
Published: (2021-08-01)
Tacrolimus intra-patient variability in pediatric liver transplantation
by: WU Haoxiang, LÜ Zicheng, HOU Yuchen, ZHANG Zijie, QIAO Ziyun, FENG Hao, XIA Qiang
Published: (2022-05-01)
by: WU Haoxiang, LÜ Zicheng, HOU Yuchen, ZHANG Zijie, QIAO Ziyun, FENG Hao, XIA Qiang
Published: (2022-05-01)
Similar Items
-
Combined Application of Tacrolimus with Cyproconazole, Hymexazol and Novel {2-(3-R-1<i>H</i>-1,2,4-triazol-5-yl)phenyl}amines as Antifungals: <i>In Vitro</i> Growth Inhibition and <i>In Silico</i> Molecular Docking Analysis to Fungal Chitin Deacetylase
by: Lyudmyla Antypenko, et al.
Published: (2023-01-01) -
Monomethyl Suberate Screening for Antifungal Activity, Molecular Docking and Drug-Like Properties
by: Lyudmyla Antypenko, et al.
Published: (2018-12-01) -
Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
by: Emrah Günay
Published: (2020-09-01) -
Tacrolimus—why pharmacokinetics matter in the clinic
by: Lino Henkel, et al.
Published: (2023-08-01) -
Anemia hemolítica microangiopática induzida por tacrolimus e ciclosporina A Microangiopathic hemolytic anemia induced by tacrolimus and ciclosporine A
by: Rafael S. Vasconcelos, et al.
Published: (2008-12-01)
